Allisyn

• The combination of garlic bulb and cinnamon bark
• Used in herbal medicine to support cardiovascular health and reduce high blood lipid levels in adults
• Provides 10 mg of allicin per daily dose
• Each daily dose contains 80 cinnamic aldehyde

Description

Allisyn is a mixture of allicin and cinnamic aldehyde that is traditionally used to support cardiovascular health. The main bioactive component of garlic is allicin. When broken down, this sulfur-containing compound is responsible for garlic's characteristic smell. Recent research indicates that long-term garlic consumption can effectively reduce overall cholesterol levels to higher baseline values. Garlic contributes to the reduction of elevated lipid levels by inhibiting cholesterol synthesis and LDL oxidation in the liver. In a randomized, placebo-controlled trial involving 150 hyperlipidemic adults, a daily intake of 800 mg of garlic powder capsules (providing 2 mg of allicin) for six weeks significantly reduced total and LDL cholesterol by approximately 12% and 17% respectively. Similarly, in vitro research demonstrates that cinnamic aldehyde reduces the mRNA levels of PPAR-γ and SREBP1, transcription factors that regulate lipid synthesis and storage. Cinnamic aldehyde and garlic promote endothelial cell function by decreasing lipid peroxidation and inhibiting the activities of the inflammation-promoting transcription factor NFκB.

Dosage

Adults: Take one capsule twice daily with meals, or as directed by your practitioner.

Nutritional information

Each capsule contains: Garlic (Allium sativum) Bulb Powder 500 mg Providing: Allicin 5 mg Cinnamon (Cinnamomum verum) Bark 200 mg Providing: Cinnamaldehyde 40 mg

Non-medicinal ingredients: Hydroxypropylmethycellulose, silica, magnesium stearate.